Literature DB >> 15168100

Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys.

J G Hugtenburg1, E R Heerdink, A C G Egberts.   

Abstract

OBJECTIVE: The aim of the study was to determine the changes in consumption of psychotropic drugs by children aged less than 18 years during the years 1995 to 2001 in the Netherlands.
METHODS: The year prevalence of antipsychotics, benzodiazepines, antidepressants and psychostimulants for boys and girls under 18 years was determined using electronic pharmacy dispensing records obtained from the PHARMO database.
RESULTS: The overall prevalence of psychotropic drugs increased from 11.1 per 1000 in 1995 to 22.9 per 1000 in 2001. This increase could almost completely be attributed to the increase in the use of psychostimulants, i.e. methylphenidate, which increased from 1.7 per 1000 children in 1995 to 10.0 per 1000 in 2001. For the other psychotropic drugs, no or only a small increase was seen. For both boys and girls, the use of psychostimulants was highest in the age group of 5-14 years.
CONCLUSION: During the years 1995-2001, the consumption of psychotropic drugs by children in the Netherlands has more than doubled. This increase could largely be attributed to an increased use of the psychostimulant methylphenidate by boys of the age 5-14 years.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15168100     DOI: 10.1007/s00228-004-0765-9

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

Review 1.  Personal paper: attention deficit hyperactivity disorder is underdiagnosed and undertreated in Britain.

Authors:  G D Kewley
Journal:  BMJ       Date:  1998-05-23

2.  Prevalence variations in psychotropic treatment of children.

Authors:  J M Zito; D J Safer; M A Riddle; R E Johnson; S M Speedie; M Fox
Journal:  J Child Adolesc Psychopharmacol       Date:  1998       Impact factor: 2.576

3.  Psychotropic medication in children: a study from the Netherlands.

Authors:  E Schirm; H Tobi; J M Zito; L T de Jong-van den Berg
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

Review 4.  National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995.

Authors:  L M Robison; D A Sclar; T L Skaer; R S Galin
Journal:  Clin Pediatr (Phila)       Date:  1999-04       Impact factor: 1.168

5.  Stimulant treatment in Maryland public schools.

Authors:  D J Safer; M Malever
Journal:  Pediatrics       Date:  2000-09       Impact factor: 7.124

6.  Increased methylphenidate usage for attention deficit disorder in the 1990s.

Authors:  D J Safer; J M Zito; E M Fine
Journal:  Pediatrics       Date:  1996-12       Impact factor: 7.124

  6 in total
  19 in total

Review 1.  Study designs in paediatric pharmacoepidemiology.

Authors:  Katia Verhamme; Miriam Sturkenboom
Journal:  Eur J Clin Pharmacol       Date:  2010-11-25       Impact factor: 2.953

2.  A European perspective on paedo-psychiatric pharmacoepidemiology.

Authors:  Hans-Christoph Steinhausen
Journal:  World Psychiatry       Date:  2013-06       Impact factor: 49.548

Review 3.  Recent international trends in psychotropic medication prescriptions for children and adolescents.

Authors:  Hans-Christoph Steinhausen
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-11-08       Impact factor: 4.785

4.  The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.

Authors:  Ingrid Schubert; Ingrid Köster; Gerd Lehmkuhl
Journal:  Dtsch Arztebl Int       Date:  2010-09-10       Impact factor: 5.594

5.  Prevalence of methylphenidate use among Israeli children: 1998-2004.

Authors:  Shlomo Vinker; Rina Vinker; Asher Elhayany
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

6.  Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands.

Authors:  Els F van den Ban; Patrick C Souverein; Herman van Engeland; Hanna Swaab; Toine C G Egberts; Eibert R Heerdink
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-05-28       Impact factor: 4.328

7.  Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10-year population-based study.

Authors:  Ainhoa Gómez-Lumbreras; Ana Garcia Sangenis; Oriol Prat Vallverdú; Anna Gatell Carbó; Cristina Vedia Urgell; Laura Gisbert Gustemps; Xavier Bruna Pérez; Antoni Ramos Quiroga; Rosa Morros Pedrós
Journal:  Psychopharmacology (Berl)       Date:  2021-03-10       Impact factor: 4.530

8.  Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK.

Authors:  Yingfen Hsia; Karyn Maclennan
Journal:  Eur J Epidemiol       Date:  2009-03-05       Impact factor: 8.082

9.  Prevalence of methylphenidate use among Canadian children following parental divorce.

Authors:  Lisa A Strohschein
Journal:  CMAJ       Date:  2007-06-05       Impact factor: 8.262

10.  Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS).

Authors:  Hildtraud Knopf; Heike Hölling; Michael Huss; Robert Schlack
Journal:  BMJ Open       Date:  2012-11-23       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.